Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan.

Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg (2007) 2.53

Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg (2003) 2.02

Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01

MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med (2008) 1.99

Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. Gut (2005) 1.91

Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg (2007) 1.82

Should hepatomas be treated with hepatic resection or transplantation? Cancer (1999) 1.54

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut (2005) 1.54

Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br J Cancer (2005) 1.51

Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol (2005) 1.50

Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg (2004) 1.46

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology (1997) 1.36

Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg (2003) 1.35

Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (2000) 1.33

Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci (2007) 1.31

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut (2002) 1.29

Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma. J Gastroenterol (2007) 1.06

Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol (2011) 1.06

Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase. Neoplasia (1999) 1.00

Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res (2007) 0.98

Resection of peritoneal implantation of hepatocellular carcinoma after hepatic resection: risk factors and prognostic analysis. World J Surg (2004) 0.96

Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol (2000) 0.96

Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol (2003) 0.96

Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations. World J Gastroenterol (2014) 0.96

Efficacy of hepatic resection for hepatocellular carcinomas larger than 10 cm. World J Surg (2005) 0.93

Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis. PLoS One (2014) 0.92

Hepatectomy as treatment of choice for hepatocellular carcinoma in elderly cirrhotic patients. World J Surg (2005) 0.90

Causes of death in patients with unresectable hepatocellular carcinoma. Dig Dis Sci (2007) 0.88

Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood. Surg Today (2005) 0.88

Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion. World J Surg (2013) 0.86

Encapsulated hepatocellular carcinoma: CT-pathologic correlations. Eur Radiol (2006) 0.84

Laparoscopic radiofrequency ablation of unresectable hepatocellular carcinoma: long-term follow-up. HPB (Oxford) (2008) 0.84

Early recurring hepatocellular carcinoma after partial hepatic resection: preoperative CT findings. Korean J Radiol (2001) 0.84

Impact of age on the survival of patients with liver cancer: an analysis of 27,255 patients in the SEER database. Oncotarget (2015) 0.83

Prognostic impact of Fas ligand on hepatocellular carcinoma after hepatectomy. World J Surg (2004) 0.82

Safety and efficacy of partial hepatectomy for huge (≥10 cm) hepatocellular carcinoma: a systematic review. Med Sci Monit (2011) 0.82

Improved long-term survival after liver resection for hepatocellular carcinoma in the modern era: retrospective study from HCV-endemic areas. World J Surg (2006) 0.82

Hepatocellular carcinoma--rising incidence, changing therapeutic strategies. Wien Med Wochenschr (2006) 0.82

Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma. World J Gastroenterol (2015) 0.81

Fibrosis and inflammatory activity in noncancerous tissue and mitotic index of cancer tissue in patients with hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection. Dig Dis Sci (2003) 0.81

Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.79

Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma. Chin J Cancer (2016) 0.78

Early effect of hepatic artery TNF-alpha infusion on systemic hemodynamics and inflammation: a dose-response study in pigs. Int J Colorectal Dis (2009) 0.78

Stereotactic body radiotherapy combined with transarterial chemoembolization for huge (≥10 cm) hepatocellular carcinomas: A clinical study. Mol Clin Oncol (2014) 0.78

Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1. Oncotarget (2016) 0.77

Clinicopathological features and prognostic factors of young patients with surgically treated liver cancer. Medicine (Baltimore) (2015) 0.77

Prognostic index for survival in patients after treatment for primary hepatocellular carcinoma. Dig Dis Sci (2007) 0.77

An accurate predictor of liver failure and death after hepatectomy: a single institution's experience with 478 consecutive cases. World J Gastroenterol (2014) 0.77

Management strategies for hepatocellular carcinoma: old certainties and new realities. Clin Exp Med (2015) 0.76

Clinicopathological analysis of CD8-positive lymphocytes in the tumor parenchyma and stroma of hepatocellular carcinoma. Oncol Lett (2014) 0.76

Quantitative Assessment of the Portal Pressure for the Liver Surgery Using Serological Tests. Ann Surg (2016) 0.75

Prognostic factors after hepatic resection for the single hepatocellular carcinoma larger than 5 cm. Ann Surg Treat Res (2016) 0.75

Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus. Onco Targets Ther (2016) 0.75

Hepatocellular carcinoma arising from autoimmune hepatitis: report of a case. Surg Today (2007) 0.75